TAT-11: “Ac-225-NM600 Targeted Alpha Therapy Extends Survival in a Model of Triple Negative Breast Cancer”
Presented by: Reinier Hernandez, Ph.D., Department of Radiology, University of Wisconsin-Madison, Madison, Wisconsin, United States
Written by: William Carithers, Lawrence Berkeley National Laboratory at the 11th International Symposium on Targeted Alpha Therapy (TAT-10) April 1 - April 4, 2019 - Ottawa, ON, Canada